Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02045823 · ClinicalTrials.gov registry record
OCT Agreement and Precision Study
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 66
- Enrollment target
NCT02045823: Completed study, sponsored by Topcon Medical Systems.
NCT02045823 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02045823 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
To demonstrate clinical substantial equivalence of 3D OCT-1 Maestro as comparable to the commercially available iVue and NW-300. Also, to demonstrate clinical substantial equivalence of 3D OCT-2000 Maestro as comparable to the commercially available NW-300.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02045823
The ClinicalTrials.gov registry entry for NCT02045823 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topcon Medical Systems, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02045823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02045823 about?
NCT02045823 is a clinical study titled "OCT Agreement and Precision Study". To demonstrate clinical substantial equivalence of 3D OCT-1 Maestro as comparable to the commercially available iVue and NW-300. Also, to demonstrate clinical substantial equivalence of 3D OCT-2000 Maestro as comparable to the commercially available NW-300.
What is the current status of trial NCT02045823?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2014-01. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT02045823?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.